Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
Benzinga’s Top Ratings Upgrades, Downgrades For September 13, 2022
Upgrades
See all analyst ratings upgrades.
Baird Initiates Coverage On ESAB with Outperform Rating, Announces Price Target of $53
Baird analyst Mircea Dobre initiates coverage on ESAB (NYSE:ESAB) with a Outperform rating and announces Price Target of $53.
ESAB Q2 EPS $1.14 Beats $1.01 Estimate, Sales $661.00M Beat $635.95M Estimate
ESAB (NYSE:ESAB) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.01 by 12.87 percent. The company reported quarterly sales of $661.00 million which beat the analyst
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.